Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 24 March 2006:
Vol. 311. no. 5768, pp. 1778 - 1780
DOI: 10.1126/science.1123500
Prev | Table of Contents | Next

Reports

Immunological Reversal of Autoimmune Diabetes Without Hematopoietic Replacement of ß Cells

Anish Suri,* Boris Calderon, Thomas J. Esparza, Katherine Frederick, Patrice Bittner, Emil R. Unanue*

Type 1 diabetes mellitus results from the autoimmune destruction of the ß cells of the pancreatic islets of Langerhans and is recapitulated in the nonobese diabetic strain of mice. In an attempt to rescue islet loss, diabetic mice were made normoglycemic by islet transplantation and immunization with Freund's complete adjuvant along with multiple injections of allogeneic male splenocytes. This treatment allowed for survival of transplanted islets and recovery of endogenous ß cell function in a proportion of mice, but with no evidence for allogeneic splenocyte–derived differentiation of new islet ß cells. Control of the autoimmune disease at a crucial time in diabetogenesis can result in recovery of ß cell function.

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.

* To whom correspondence should be addressed. E-mail: anish{at}pathology.wustl.edu (A.S.); unanue{at}pathbox.wustl.edu (E.R.U.)

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Innocuous IFN{gamma} induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production.
R. Jain, D. M. Tartar, R. K. Gregg, R. D. Divekar, J. J. Bell, H.-H. Lee, P. Yu, J. S. Ellis, C. M. Hoeman, C. L. Franklin, et al. (2008)
J. Exp. Med. 205, 207-218
   Abstract »    Full Text »    PDF »
Mesenchymal Stem Cells Cooperate with Bone Marrow Cells in Therapy of Diabetes.
V. S. Urban, J. Kiss, J. Kovacs, E. Gocza, V. Vas, E. Monostori, and F. Uher (2008)
Stem Cells 26, 244-253
   Abstract »    Full Text »    PDF »
Dual T Cell Receptor Expressing CD8+ T Cells with Tumor- and Self-Specificity Can Inhibit Tumor Growth without Causing Severe Autoimmunity.
M. Weinhold, D. Sommermeyer, W. Uckert, and T. Blankenstein (2007)
J. Immunol. 179, 5534-5542
   Abstract »    Full Text »    PDF »
Hematopoietic Stem Cells Derived From Adult Donors Are Not a Source of Pancreatic {beta}-Cells in Adult Nondiabetic Humans.
A. E. Butler, A. Huang, P. N. Rao, A. Bhushan, W. J. Hogan, R. A. Rizza, and P. C. Butler (2007)
Diabetes 56, 1810-1816
   Abstract »    Full Text »    PDF »
Elimination of insulitis and augmentation of islet beta cell regeneration via induction of chimerism in overtly diabetic NOD mice.
C. Zhang, I. Todorov, C.-L. Lin, M. Atkinson, F. Kandeel, S. Forman, and D. Zeng (2007)
PNAS 104, 2337-2342
   Abstract »    Full Text »    PDF »
Pancreas and beta-cell development: from the actual to the possible.
L. C. Murtaugh (2007)
Development 134, 427-438
   Abstract »    Full Text »    PDF »
Reversal of Type 1 Diabetes in Mice.
D. L. Faustman (2007)
N. Engl. J. Med. 356, 311-312
   Full Text »    PDF »
Recovery of Islet {beta}-Cell Function in Streptozotocin- Induced Diabetic Mice: An Indirect Role for the Spleen.
D. Yin, J. Tao, D. D. Lee, J. Shen, M. Hara, J. Lopez, A. Kuznetsov, L. H. Philipson, and A. S. Chong (2006)
Diabetes 55, 3256-3263
   Abstract »    Full Text »    PDF »
Comment on Papers by Chong et al., Nishio et al., and Suri et al. on Diabetes Reversal in NOD Mice.
D. L. Faustman, S. D. Tran, S. Kodama, B. M. Lodde, I. Szalayova, S. Key, Z. E. Toth, and E. Mezey (2006)
Science 314, 1243a
   Abstract »    Full Text »    PDF »
Response to Comment on Chong et al. on Diabetes Reversal in NOD Mice.
A. S. Chong, J. Shen, J. Tao, D. Yin, A. Kuznetsov, M. Hara, and L. H. Philipson (2006)
Science 314, 1243b
   Abstract »    Full Text »    PDF »
Response to Comment on Nishio et al. on Diabetes Reversal in NOD Mice.
J. Nishio, J. L. Gaglia, S. E. Turvey, C. Campbell, C. Benoist, and D. Mathis (2006)
Science 314, 1243c
   Abstract »    Full Text »    PDF »
Response to Comment on Suri et al. on Diabetes Reversal in NOD Mice.
A. Suri and E. R Unanue (2006)
Science 314, 1243d
   Abstract »    Full Text »    PDF »
Mechanistic insights into targeting T cell membrane proteinase to promote islet {beta}-cell rejuvenation in type 1 diabetes.
A. Y. Savinov, D. V. Rozanov, and A. Y. Strongin (2006)
FASEB J 20, 1793-1801
   Abstract »    Full Text »    PDF »
Reversal of type 1 diabetes in mice..
D. A. Melton (2006)
N. Engl. J. Med. 355, 89-90
   Full Text »    PDF »
Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration..
A. S. Chong, J. Shen, J. Tao, D. Yin, A. Kuznetsov, M. Hara, and L. H. Philipson (2006)
Science 311, 1774-1775
   Abstract »    Full Text »    PDF »
Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution..
J. Nishio, J. L. Gaglia, S. E. Turvey, C. Campbell, C. Benoist, and D. Mathis (2006)
Science 311, 1775-1778
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)